DETECTNCT05068011
Differential Target Multiplexed Spinal Cord Stimulation
At risk: Primary completion moved at least 4 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 14 words Show 5 more changesShow less
- Trial status changed: Unknown → Active, Not Recruiting
- Primary and study completion pushed from Aug 2026 to Jan 2027
- Secondary endpoints: details revised at 1 of 20 entries
- Site details revised at 14 of 14 sites
- Publications: details revised at 1 of 1 entry
- Minor Changed Registry marked status Unknown; last known: Recruiting
- Notable Primary and study completion dates: Mar 2024 to Aug 2026
- Trial status: Recruiting to Unknown
- Enrollment target: 200 to 250
- Study sites: 1 to 14
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Sep 30, 2021 to Oct 6, 2021
- Site details revised
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Overall pain intensity with Visual Analogue Scale (VAS)
Timeframe: The change between the baseline screening and the evaluation 1 month after DTM stimulation, 6 months and 12 months
Secondary (20)
Back pain intensity with Visual Analogue Scale (VAS)
Leg pain intensity with Visual Analogue Scale (VAS)
Pain medication use
Functional disability
Health related quality of life
Show 15 moreShow less
Patient global impression of change
Clinical holistic responder status
Patients' individual competencies for self-management
Work status
Pain catastrophizing
Symptoms of central sensitisation.
Anxiety and Depression.
Healthcare utilisation.
Time spent in body postures
(Serious) adverse events
Proportion of successful DTM trials.
Battery consumption
Prevalence of technical issues with regard to DTM SCS programming
DTM SCS stimulation parameters
Patient expectations concerning SCS
Arms and interventions
Spinal cord stimulation
Patients will receive differential target multiplexed spinal cord stimulation
Devices: Spinal Cord Stimulation
Sites
14 sites in 1 country